The Transplantation Society is a non-profit NGO providing global leadership in transplantation. Our core mission include the development of the science and clinical practice, scientific communication, continuing education and guidance on the ethical practice.

Subscribe to Tribune PulseView PAST ISSUES

header1b 3

TTS 2018 Thank you and Access to recording and photos

header tts2018

TTS MEMBERS CLICK HERE TO ACCESS THE RECORDINGS

CLICK HERE TO VIEW THE PHOTOS

The Transplantation Society along with the Sociedad Española de Transplant and the Sociedad Madrileña de Trasplantes want to THANK YOU FOR YOUR PARTICIPATION and also acknowledge the exceptional contributions, creativity and support from the many stakeholders and participants that made TTS 2018 the outstanding success that it has become.

ttscouncil

We wish to single out the following groups and convey our deepest thanks to their coordinating leaders:

  • To the many who served on a multitude of sub-committees of the TTS 2018, we wish to express our deepest thanks and appreciation for your commitment over the last two years and the voice of your wisdom on countless decisions made for this Congress.
  • To the numerous award, abstract, plenary, SOTA and Postgraduate Course speakers, session chairs and abstract reviewers from around the world, who contributed their expertise to ensuring that this TTS 2018 had a deep and robust scientific program.
  • To the various sections (CTRMS, TID, IXA and IPTA) and other groups (WTGF, WIT, vGTL, DOI and ITNS) who have created an interesting pre-congress workshop program.
  • To the Young Members Committee and their leaders who organized career networking activities, and delivered a rich cultural and human co-curricular component for the Congress trainees, we wish to convey our most heartfelt appreciation.
  • To the Women in Transplantation Committee for having hosted several learning and networking activities throughout the Congress and thus having promoted the role and furthered the understanding of women in transplantation.
  • To the sponsors and exhibitors without whom it would have been impossible to provide our community with a very rich content in the Exhibit Hall.
  • To the logistics support companies (Rent Multimedia, El Antiguo Convento, Servis, Barcelo Congresos and IFEMA) who provided the staging, audiovisual support, meals at all events and lunches/breaks, signage and booth building, etc; all of which contributed to create a unique ambiance for all aspects of the Congress.
  • The TTS PCO team, for their passion, energy and heart that made this Congress the unique human experience that it became!

 tts2018 recordings

TTS 2018 in Photos

photosd

TTS PRESIDENT AND PRESIDENT-ELECT VISIT TTS IHQ

three

On Wednesday, July 25, the staff at TTS IHQ were pleased to welcome Professor Mehmet Haberal and Dr. Marcelo Cantarovich to our International Headquarters. For many of the staff, it was their first time meeting our new President and it offered Professor Haberal the opportunity to inspire our IHQ team about the great work TTS does around the world.

August Issue of Transplantation

lww

Starting with machine preservation in its many guises, this issue includes a contemporary analysis of the strategies and barriers to transplant tolerance. How many donors could there be, is a question asked and answered. What is the best model of HLA heterogeneity to predict development of DSAs? There is interest for liver, lung, cardiac, intestinal, composite tissue and Islet transplant programs. Much to read and a whole month to read it in.

CLICK HERE TO READ THIS ISSUE (Rquires LOGIN for full articles) 

TTS MEMBERS CLICK HERE for full ACCESS through our referral link 

MESOT 2018 is almost here!

mesot

TTS will be exhibiting at MESOT and a large number of TTS members will be attending or presenting at the Congress. There is still time to register, see link below!

Click here to visit www.mesot2018.com for more information


In the News

Progress in Graft Survival Has Slowed

July 27 - A team led by Maarten Naesens, MD, of University Hospitals Leuven in Belgium, conducted a cohort study of 108,787 recipients of deceased (brain death) donor kidneys across 21 European countries from 1986 to 2015. From 1986 to 1999, 1-, 5- and 10-year hazard rates for allograft loss after transplantation declined by 64%, 53%, and 45%, respectively. From 2000 to 2015, however, these rates declined by 22%, 47%, and 64%, respectively.

READ THE FULL ARTICLE


3 biological parents, 1 child, and an international controversy

July 27 - The story of mitochondrial replacement therapy shows how ethically tricky genetic manipulation is becoming.

READ THE FULL ARTICLE


How have pediatric VADs advanced and what's next?

July 18 - Pediatric ventricular assist devices (VADs) have been associated with better survival to heart transplantation in recent years but infants and those with congenital heart disease (CHD) continue to have worse outcomes, researchers reported in the Journal of the American College of Cardiology.

READ THE FULL ARTICLE


Legal Liver Transplant Focuses Attention On The Human Organ Trade

July 27 - In surely one of the most bizarre stories of recent weeks, former FC Barcelona president, Sandro Rosell, was forced to deny claims that he illegally purchased a human liver for ex-Barcelona defender Eric Abidal in 2012, after a report in Spanish newspaper El Confidencial claimed police had intercepted phone calls of Rosell allegedly admitting the purchase. A statement by FC Barcelona flatly denied the allegations, and pointed out that a Catalan court had shelved an investigation into the matter in 2017.

READ THE FULL ARTICLE

Subscribe to Tribune PulseView PAST ISSUES

2018 07 19

ISN-TTS Sister Transplant Centers Program

Learn to make your application stand out by watching this webinar recording. This presentation will guide you through each step of the application process and provide some handy tips on how to prepare a successful application.

Click here to watch the webinar recording

Science and Transplantation Expedition to Kyrgyzstan

medawar2

Then President-Elect, and now, as of July 4, President of The Transplantation Society, and Founder President of Baskent University, Prof. Mehmet Haberal, travelled to Bishkek, the capital of Kyrgyzstan, on June 17, 2018, for his latest science and transplantation activities expedition in the Turkic World. With a full program of meetings lined up, Prof. Haberal began by meeting with the Minister of Health, followed by meetings with the Chair of the Health Commission, various members of parliament, university rectors, and medical faculty staff and students.

medawar2

Click here to read the full article

Highlighted article in Transplantation

Submitted by Dr Peri Kocabayoglu, Editorial Fellow, Transplantation.

De Graav GN, van der Zwan M, Baan CC, Janssen J, Hesselink DA. Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms. Transplant Direct. 2018;4:e350.

In this case report, a 54-year-old male kidney transplant recipient with preexisting type 2 diabetes mellitus (DM) demonstrated a rapid improvement of glucose tolerance when switched from tacrolimus to belatacept. Although belatacept, an inhibitor of the CD28-80/86 pathway, is less diabetogenic than tacrolimus, there have thus far not been any data on safety or efficacy regarding insulin sensitivity when converting from a calcineurin inhibitor (CNI) to a costimulatory blockade immunosuppression.

Belatacept does neither induce hyperglycemia, nor posttransplant diabetes mellitus (PTDM). However, increased rates acute rejection rates have been reported in patients on a belatacept-based immunosuppression.

READ MORE

Rapid 3D Printing Of High-Res, Viable Human Organs Possible

txdirect

July 11 - In 2017, researchers at Prellis Biologics, claimed to have reached unprecedented speeds, while printing quality human tissue, along with its active capillaries. This innovation could pave the way for the large-scale manufacture of tissues in the future.

READ THE FULL ARTICLE


In the News

New York organ collection agency, nation’s second-largest, threatened with closure

July 11 - The government is threatening to close one of the country’s largest “organ procurement organizations” for poor performance, a rare move against a nonprofit that collects kidneys, livers, hearts and other organs used in transplantation. In a letter last month to Live­OnNY, which recovers organs in the New York City area, the Centers for Medicare and Medicaid Services (CMS) said it “will not renew its agreement with LiveOnNY” when the contract is set to expire Jan. 31. The CMS rejected LiveOnNY’s request for reconsideration Monday.

READ THE FULL ARTICLE


The Alliance for Regenerative Medicine Publishes Position on Proposed Regulation on Health Technology Assessment and Amending Directive 2011/24/EU

July 11 - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing multiple stakeholder groups comprising the cell and gene therapy and broader regenerative medicine and ATMP sector, today published its position in response to the proposal for a Regulation of the European Parliament and of the Council on health technology assessment and amending Directive 2011/24/EU (COM(2018) 51 final).

READ THE FULL ARTICLE


37 Convicted for Multi-Million Dollar Illegal Organ Harvesting Operation in Egypt

July 12 - The convicted individuals were handed down sentences ranging from 3 to 15 years. In total, 41 people—including doctors and nurses—were implicated in the probe by Egyptian authorities, Reuters reported. Three people were also cleared by the criminal court, and one had died before the trial was completed. The suspects were detained in a 2016 raid, at which time millions of dollars were also confiscated.

READ THE FULL ARTICLE


Researchers detect presence of IgE antibodies after kidney transplantation

July 17 - Many donor kidneys that are transplanted are rejected by the recipient within ten years after transplantation. One reason for this are immunoglobulin G antibodies (IgG), which act against human leukocyte antigens (HLA), a tissue characteristic on transplants, and cause rejection. As a result, IgG antibodies are biomarkers for an increased risk of later graft loss.

READ THE FULL ARTICLE

Official Sections of The Transplantation Society

ctsisodp new logo v7